Table of Contents

November 1, 2024; Volume 65,Issue 11

  1. Calais, Jeremie

    1. Open Access
      Best Patient Care Practices for Administering PSMA-Targeted Radiopharmaceutical Therapy
      Jeremie Calais, Michael J. Morris, Ayse Tuba Kendi, Arash Rezazadeh Kalebasty, Ronald Tutrone, Michael J. Anderson and Oliver Sartor
      Journal of Nuclear Medicine November 1, 2024, 65 (11) 1666-1671; DOI: https://doi.org/10.2967/jnumed.124.268363
    2. Efficacy and Toxicity of [<sup>177</sup>Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data
      Efficacy and Toxicity of [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data
      Vishnu Murthy, Andrew F. Voter, Kathleen Nguyen, Martin Allen-Auerbach, Lucia Chen, Sydney Caputo, Elisa Ledet, Abraham Akerele, Abuzar Moradi Tuchayi, Courtney Lawhn-Heath, Tingchang Wang, Michael A. Carducci, Martin G. Pomper, Channing J. Paller, Johannes Czernin, Lilja B. Solnes, Thomas A. Hope, Oliver Sartor, Jeremie Calais and Andrei Gafita
      Journal of Nuclear Medicine November 1, 2024, 65 (11) 1740-1744; DOI: https://doi.org/10.2967/jnumed.124.267816
    3. Correlation of FAPI PET Uptake with Immunohistochemistry in Explanted Lungs from Patients with Advanced Interstitial Lung Disease
      Correlation of FAPI PET Uptake with Immunohistochemistry in Explanted Lungs from Patients with Advanced Interstitial Lung Disease
      Masatoshi Hotta, Grace Hyun J. Kim, Vilasinee Rerkpichaisuth, Pang Yu Teng, Wesley R. Armstrong, Giuseppe Carlucci, Magnus Dahlbom, Fereidoun Abtin, Shahrzad M. Lari, Gregory A. Fishbein, Johannes Czernin, Elizabeth R. Volkmann, S. Sam Weigt and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2024, 65 (11) 1789-1794; DOI: https://doi.org/10.2967/jnumed.124.268351

  2. Caputo, Sydney

    1. Efficacy and Toxicity of [<sup>177</sup>Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data
      Efficacy and Toxicity of [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data
      Vishnu Murthy, Andrew F. Voter, Kathleen Nguyen, Martin Allen-Auerbach, Lucia Chen, Sydney Caputo, Elisa Ledet, Abraham Akerele, Abuzar Moradi Tuchayi, Courtney Lawhn-Heath, Tingchang Wang, Michael A. Carducci, Martin G. Pomper, Channing J. Paller, Johannes Czernin, Lilja B. Solnes, Thomas A. Hope, Oliver Sartor, Jeremie Calais and Andrei Gafita
      Journal of Nuclear Medicine November 1, 2024, 65 (11) 1740-1744; DOI: https://doi.org/10.2967/jnumed.124.267816

  3. Carducci, Michael A.

    1. Efficacy and Toxicity of [<sup>177</sup>Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data
      Efficacy and Toxicity of [177Lu]Lu-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer: Results from the U.S. Expanded-Access Program and Comparisons with Phase 3 VISION Data
      Vishnu Murthy, Andrew F. Voter, Kathleen Nguyen, Martin Allen-Auerbach, Lucia Chen, Sydney Caputo, Elisa Ledet, Abraham Akerele, Abuzar Moradi Tuchayi, Courtney Lawhn-Heath, Tingchang Wang, Michael A. Carducci, Martin G. Pomper, Channing J. Paller, Johannes Czernin, Lilja B. Solnes, Thomas A. Hope, Oliver Sartor, Jeremie Calais and Andrei Gafita
      Journal of Nuclear Medicine November 1, 2024, 65 (11) 1740-1744; DOI: https://doi.org/10.2967/jnumed.124.267816
    2. Initial Experience with [<sup>177</sup>Lu]Lu-PSMA-617 After Regulatory Approval for Metastatic Castration-Resistant Prostate Cancer: Efficacy, Safety, and Outcome Prediction
      Initial Experience with [177Lu]Lu-PSMA-617 After Regulatory Approval for Metastatic Castration-Resistant Prostate Cancer: Efficacy, Safety, and Outcome Prediction
      Andrei Gafita, Andrew Voter, Somya Shesadri, Avery Spitz, Catherine H. Marshall, Steven P. Rowe, Mark C. Markowski, Martin G. Pomper, A. Cahid Civelek, Michael A. Carducci, Samuel R. Denmeade, Jeffrey Young, Kenneth J. Pienta, Channing J. Paller and Lilja B. Solnes
      Journal of Nuclear Medicine November 1, 2024, 65 (11) 1724-1730; DOI: https://doi.org/10.2967/jnumed.124.267723

  4. Carlsen, Esben Andreas

    1. Routine Use of [<sup>64</sup>Cu]Cu-DOTATATE PET/CT in a Neuroendocrine Tumor Center: Referral Patterns and Image Results of 2,249 Consecutive Scans
      Routine Use of [64Cu]Cu-DOTATATE PET/CT in a Neuroendocrine Tumor Center: Referral Patterns and Image Results of 2,249 Consecutive Scans
      Esben Andreas Carlsen, Mathias Loft, Camilla Bardram Johnbeck, Ulrich Knigge, Seppo W. Langer, Jann Mortensen, Lotte Enevoldsen, Peter Oturai and Andreas Kjaer
      Journal of Nuclear Medicine November 1, 2024, 65 (11) 1754-1761; DOI: https://doi.org/10.2967/jnumed.124.267939

  5. Carlucci, Giuseppe

    1. Correlation of FAPI PET Uptake with Immunohistochemistry in Explanted Lungs from Patients with Advanced Interstitial Lung Disease
      Correlation of FAPI PET Uptake with Immunohistochemistry in Explanted Lungs from Patients with Advanced Interstitial Lung Disease
      Masatoshi Hotta, Grace Hyun J. Kim, Vilasinee Rerkpichaisuth, Pang Yu Teng, Wesley R. Armstrong, Giuseppe Carlucci, Magnus Dahlbom, Fereidoun Abtin, Shahrzad M. Lari, Gregory A. Fishbein, Johannes Czernin, Elizabeth R. Volkmann, S. Sam Weigt and Jeremie Calais
      Journal of Nuclear Medicine November 1, 2024, 65 (11) 1789-1794; DOI: https://doi.org/10.2967/jnumed.124.268351

  6. Carson, Richard E.

    1. Validation of a Simplified Tissue-to-Reference Ratio Measurement Using SUVR to Assess Synaptic Density Alterations in Alzheimer Disease with [<sup>11</sup>C]UCB-J PET
      Open Access
      Validation of a Simplified Tissue-to-Reference Ratio Measurement Using SUVR to Assess Synaptic Density Alterations in Alzheimer Disease with [11C]UCB-J PET
      Juan J. Young, Ryan S. O’Dell, Mika Naganawa, Takuya Toyonaga, Ming-Kai Chen, Nabeel B. Nabulsi, Yiyun Huang, Emma Cooper, Alyssa Miller, Jessica Lam, Kara Bates, Audrey Ruan, Kimberly Nelsen, Elaheh Salardini, Richard E. Carson, Christopher H. van Dyck and Adam P. Mecca
      Journal of Nuclear Medicine November 1, 2024, 65 (11) 1782-1785; DOI: https://doi.org/10.2967/jnumed.124.267419

  7. Carter, Lukas M.

    1. MIRD Pamphlet No. 30: MIRDfit—A Tool for Fitting of Biodistribution Time–Activity Data for Internal Dosimetry
      Lukas M. Carter, Juan Camilo Ocampo Ramos, Seval Beykan Schuerrle, Harry Marquis, Michael Lassmann, Wesley E. Bolch and Adam L. Kesner
      Journal of Nuclear Medicine November 1, 2024, 65 (11) 1808-1814; DOI: https://doi.org/10.2967/jnumed.124.268011

  8. Casasnovas, Olivier

    1. Precautions to Consider in the Analysis of Prognostic and Predictive Indices
      Precautions to Consider in the Analysis of Prognostic and Predictive Indices
      Loïc Chartier, Aurélien Belot, Isabelle Chaillol, Mad-Hélénie Elsensohn, Cédric Portugues, Marguerite Fournier, Clémentine Joubert, Elodie Gat, Cécile Pizot, Patrick Fogarty, Tesla Murairi, Romain Ould Ammar, Jérôme Paget, Fanny Cherblanc, Romain Ricci, Laetitia Vercellino, Salim Kanoun, Anne-Ségolène Cottereau, Catherine Thieblemont and Olivier Casasnovas
      Journal of Nuclear Medicine November 1, 2024, 65 (11) 1672-1678; DOI: https://doi.org/10.2967/jnumed.123.267021

  9. Castilloux, Jean-François

    1. Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study
      Open Access
      Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study
      Frédéric Pouliot, Fred Saad, Etienne Rousseau, Patrick O. Richard, Atefeh Zamanian, Stephan Probst, Éric Lévesque, Vincent Castonguay, Nicolas Marcoux, Michele Lodde, Daniel Juneau, Zineb Hamilou, Jean-Baptiste Lattouf, François-Alexandre Buteau, Michel Pavic, Jean-François Castilloux, Bertrand Neveu, Guillaume F. Bouvet, Catherine Allard, Amélie Tétu, Brigitte Guérin, Jean-Mathieu Beauregard and for the 3TMPO Investigators
      Journal of Nuclear Medicine November 1, 2024, 65 (11) 1710-1717; DOI: https://doi.org/10.2967/jnumed.124.268020

  10. Castonguay, Vincent

    1. Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study
      Open Access
      Intrapatient Intermetastatic Heterogeneity Determined by Triple-Tracer PET Imaging in mCRPC Patients and Correlation to Survival: The 3TMPO Cohort Study
      Frédéric Pouliot, Fred Saad, Etienne Rousseau, Patrick O. Richard, Atefeh Zamanian, Stephan Probst, Éric Lévesque, Vincent Castonguay, Nicolas Marcoux, Michele Lodde, Daniel Juneau, Zineb Hamilou, Jean-Baptiste Lattouf, François-Alexandre Buteau, Michel Pavic, Jean-François Castilloux, Bertrand Neveu, Guillaume F. Bouvet, Catherine Allard, Amélie Tétu, Brigitte Guérin, Jean-Mathieu Beauregard and for the 3TMPO Investigators
      Journal of Nuclear Medicine November 1, 2024, 65 (11) 1710-1717; DOI: https://doi.org/10.2967/jnumed.124.268020
« Previous (Pages : 1 2 3 ... 3) Next »
Back to top

In this issue